Search Results
Pages
-
Lung cancer includes non-small cell, small cell, mesothelioma, thymoma and neuroendocrine tumours. The Royal Marsden offers a full range of lung cancer treatments and care services.
-
The Lung Unit provides state-of-the-art treatment for all forms and stages of lung cancer and mesothelioma within the framework of a comprehensive clinical research programme.
-
-
On Friday [11 September 2020], NICE published new draft guidance recommending the use of lung cancer drug osimertinib for non-small cell lung cancer (NSCLC) with an EGFR mutation) for NHS patients.
-
The Lung Unit at The Royal Marsden comprises a team of clinical staff specialising in medicine, radiotherapy and diagnostic imaging.
-
Clinicians from The Royal Marsden have been in Toronto over the past few days, presenting new research and providing expert comment at this year’s World Conference on Lung Cancer (WCLC).
-
Today sees the UK launch of nivolumab, a new treatment option 'milestone' for lung cancer patients with advanced or metastatic squamous non-small cell lung cancer (NSCLC), which affects a third of all lung cancer patients.
-
In October 2013, and recently in September 2018, GPs from around the country came to The Royal Marsden, Chelsea to hear expert speakers talk about lung cancer and lymphoma.
-
-
